Rheumatology trends focus on CAR T-cell therapy and integrative wellness

The field of rheumatology is experiencing significant shifts in both clinical development and patient care approaches. In drug development, innovations in CAR T-cell therapy are expanding beyond oncology to address autoimmune diseases such as systemic lupus erythematosus, rheumatoid arthritis, and systemic sclerosis. These therapies aim to correct abnormal immune responses to induce prolonged remission. Emerging breakthroughs include dual-target CAR T (CD19/BCMA) therapies designed to target both circulating B-cells and long-lived plasma cells, as well as the development of off-the-shelf allogeneic therapies.

Complementing these medical advancements, integrative care models are increasingly incorporating nutritional and wellness services. Clinical approaches now include personalized nutritional support and individualized IV nutritional therapies—utilizing components like Vitamin B12, Magnesium, and Glutathione—to complement conventional medical treatments such as infusion therapy and physical therapy. These wellness strategies are intended to be coordinated within a patient’s broader healthcare plan to address factors like fatigue and overall function.